Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Price

Showing results (371-380 of 500) with videos related to

Pageof 50
Sort By:
Frontiers in Immunology|April 21, 2025
Repertoire-based mapping and time-tracking of T helper cell subsets in scRNA-SeqDaniil K Lukyanov, Valeriia V Kriukova, Kristin Ladell, et al.
The Journal of Clinical Investigation|December 1, 2021
Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trialSuzanne L Campion, Elena Brenna, Elaine Thomson, et al.
Scientific Reports|December 10, 2016
Chiral Sulfoxide-Induced Single Turn Peptide α-HelicityQingzhou Zhang, Fan Jiang, Bingchuan Zhao, et al.
Nature Immunology|January 5, 2021
Memory-like HCV-specific CD8<sup>+</sup> T cells retain a molecular scar after cure of chronic HCV infectionNina Hensel, Zuguang Gu, Sagar, et al.
The Journal of Allergy and Clinical Immunology|May 26, 2018
Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunityEmily S J Edwards, Julia Bier, Theresa S Cole, et al.
The Journal of Experimental Medicine|July 23, 2014
MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usageMarielle C Gold, James E McLaren, Joseph A Reistetter, et al.
Nature Medicine|January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variantYu Gao, Curtis Cai, Alba Grifoni, et al.
Molecular Cancer Therapeutics|July 11, 2007
The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptorMarco A Purbhoo, Yi Li, Deborah H Sutton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancerGraham S Taylor, Hui Jia, Kevin Harrington, et al.
Journal of Clinical Immunology|November 26, 2025
TAP-I Deficiency Presenting With Chronic Granulomatous Rubella Virus-Driven Cutaneous Ulceration: A Case Report and Scoping Literature ReviewMark J Ponsford, Emily M Carne, Kathryn Bramhall, et al.
Pageof 50

Showing results (371-380 of 500) with videos related to

Sort By:
Pageof 50
Frontiers in Immunology|April 21, 2025
Repertoire-based mapping and time-tracking of T helper cell subsets in scRNA-SeqDaniil K Lukyanov, Valeriia V Kriukova, Kristin Ladell, et al.
The Journal of Clinical Investigation|December 1, 2021
Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trialSuzanne L Campion, Elena Brenna, Elaine Thomson, et al.
Scientific Reports|December 10, 2016
Chiral Sulfoxide-Induced Single Turn Peptide α-HelicityQingzhou Zhang, Fan Jiang, Bingchuan Zhao, et al.
Nature Immunology|January 5, 2021
Memory-like HCV-specific CD8<sup>+</sup> T cells retain a molecular scar after cure of chronic HCV infectionNina Hensel, Zuguang Gu, Sagar, et al.
The Journal of Allergy and Clinical Immunology|May 26, 2018
Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunityEmily S J Edwards, Julia Bier, Theresa S Cole, et al.
The Journal of Experimental Medicine|July 23, 2014
MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usageMarielle C Gold, James E McLaren, Joseph A Reistetter, et al.
Nature Medicine|January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variantYu Gao, Curtis Cai, Alba Grifoni, et al.
Molecular Cancer Therapeutics|July 11, 2007
The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptorMarco A Purbhoo, Yi Li, Deborah H Sutton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancerGraham S Taylor, Hui Jia, Kevin Harrington, et al.
Journal of Clinical Immunology|November 26, 2025
TAP-I Deficiency Presenting With Chronic Granulomatous Rubella Virus-Driven Cutaneous Ulceration: A Case Report and Scoping Literature ReviewMark J Ponsford, Emily M Carne, Kathryn Bramhall, et al.
Pageof 50